Shapiro David 4
4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Apr 3, 2019
Insider Transaction Report
Form 4
Shapiro David
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2019-04-01$111.50/sh−482$53,743→ 40,061 total - Sale
Common Stock
2019-04-03$115.01/sh−562$64,636→ 39,499 total
Footnotes (2)
- [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock and restricted stock unit awards previously granted to the reporting person.
- [F2]This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.